1. Home
  2. IMAB vs INVE Comparison

IMAB vs INVE Comparison

Compare IMAB & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • INVE
  • Stock Information
  • Founded
  • IMAB 2014
  • INVE 1990
  • Country
  • IMAB United States
  • INVE United States
  • Employees
  • IMAB N/A
  • INVE N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • IMAB Health Care
  • INVE Technology
  • Exchange
  • IMAB Nasdaq
  • INVE Nasdaq
  • Market Cap
  • IMAB 200.9M
  • INVE 74.2M
  • IPO Year
  • IMAB 2020
  • INVE 1997
  • Fundamental
  • Price
  • IMAB $2.15
  • INVE $3.24
  • Analyst Decision
  • IMAB Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • IMAB 2
  • INVE 3
  • Target Price
  • IMAB $6.00
  • INVE $6.50
  • AVG Volume (30 Days)
  • IMAB 982.8K
  • INVE 69.3K
  • Earning Date
  • IMAB 05-15-2025
  • INVE 08-07-2025
  • Dividend Yield
  • IMAB N/A
  • INVE N/A
  • EPS Growth
  • IMAB N/A
  • INVE N/A
  • EPS
  • IMAB N/A
  • INVE 3.12
  • Revenue
  • IMAB N/A
  • INVE $25,239,000.00
  • Revenue This Year
  • IMAB N/A
  • INVE N/A
  • Revenue Next Year
  • IMAB N/A
  • INVE $9.00
  • P/E Ratio
  • IMAB N/A
  • INVE $1.04
  • Revenue Growth
  • IMAB N/A
  • INVE N/A
  • 52 Week Low
  • IMAB $0.60
  • INVE $2.86
  • 52 Week High
  • IMAB $3.08
  • INVE $4.35
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 50.70
  • INVE 49.66
  • Support Level
  • IMAB $2.00
  • INVE $3.10
  • Resistance Level
  • IMAB $2.95
  • INVE $3.25
  • Average True Range (ATR)
  • IMAB 0.34
  • INVE 0.11
  • MACD
  • IMAB -0.08
  • INVE -0.00
  • Stochastic Oscillator
  • IMAB 15.79
  • INVE 55.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.

Share on Social Networks: